Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2007
11/15/2007US20070266457 Root-Specific and Xylem Parenchyma-Specific Promoter
11/15/2007US20070266456 Methods and compositions for obtaining marker-free transgenic plants
11/15/2007US20070266455 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms Shewanella japonica and Shewanella olleyana; plants and microorganisms that produce lipids
11/15/2007US20070266454 comprising a plant transformation vector comprising a nucleotide sequence that encodes a DRO3 polypeptide; genetic engineering
11/15/2007US20070266453 comprising a plant transformation vector comprising a nucleotide sequence that encodes a DRO3 polypeptide; genetic engineering
11/15/2007US20070266451 Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene
11/15/2007US20070266450 Non-human animal alzheimer's disease model and uses thereof
11/15/2007US20070265438 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
11/15/2007US20070265437 siRNA targeting testes development-related NYD-SP21 (NYD-SP21)
11/15/2007US20070265436 Nucleotide sequences coding tumor-associated antigenic target polypeptide specific immunoglobulins for use in detection and prevention of cell proliferative disorders
11/15/2007US20070265220 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/15/2007US20070265219 Modulation of thyroid hormone receptor interactor 3 expression
11/15/2007US20070265217 Single Nucleotide Polymorphisms as Prognostic Tool to Diagnose Adverse Drug Reactions (Adr) and Drug Efficacy
11/15/2007US20070265205 nucleotide sequence that code an insecticidal protein for resistance against coleopteran pest the corn rootworm
11/15/2007US20070265199 comprising an A1 domain having a calcium binding site; hemophilia A; antihemophilia agents
11/15/2007US20070265198 Nucleic Acids and Polypeptides of C1 Bacteriophage and Uses Thereof
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264726 Microchannel array component, microchannel array for recovering biomolecules, and method for recovering biomolecules
11/15/2007US20070264716 Methods and materials for the transformation of the yeast Pichia ciferrii
11/15/2007US20070264715 Proteins Involved in Signal Transduction
11/15/2007US20070264714 Growth differentiation factor-9 regulatory sequences and uses therefor
11/15/2007US20070264711 Human pellino polypeptides
11/15/2007US20070264709 pluripotent cell comprising a sequence encoding a selectable marker operatively linked to a promoter of a gene selected from the group consisting of sox-1, sox-2, sox-3, Pax 3, delta-1, Mash-1, Math 4a, Pax 6, beta 3-tubulin, synapsin-1, MAP2/tau, GFAP, GABA and islet-1/2
11/15/2007US20070264702 Method of Regulating Heterologous Protein Expression Controlled by Salicylic Deratives in Micro-Organisms Associated with Higher Organisms
11/15/2007US20070264693 Hyphal growth in fungi
11/15/2007US20070264692 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
11/15/2007US20070264691 Optimization of Coronatine Production in a Genetically Improved Strain of Pseudomonas Syringae
11/15/2007US20070264690 Nucleic acids encoding lettuce big-vein viral proteins and utilization thereof
11/15/2007US20070264689 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
11/15/2007US20070264687 Recombinant triplex scaffold-based polypeptides
11/15/2007US20070264686 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer treatment
11/15/2007US20070264685 Polynucleotides encoding cytokine receptor
11/15/2007US20070264681 Determining the transition between different phases of the cell cycle in mammalian cells; non-destructive
11/15/2007US20070264642 Direct multiplex characterization of genomic DNA
11/15/2007US20070264632 contacting the sample with a suicide substrate that covalently modifies a terpene synthase, results in covalent binding of the substrate to an amino acid of the enzyme to form a covalently modified enzyme; determining an amino acid sequence of at least a portion of the covalently modified enzyme
11/15/2007US20070264631 Using allelic profile of human insulin receptor substrate 2 gene as evaluative tool in prediciting vesnarinone induced reduction in blood granulocytes
11/15/2007US20070264627 Retrovirus from the HIV group and its use
11/15/2007US20070264408 testing the DNA in its milk of the bovine animal; for identifying a physical trait of an animal, determine the cow has the absence of the beta -casein A1 protein or the percentage of saturated fats
11/15/2007US20070264321 Method of treating skin wounds with vectors encoding hepatocyte growth factor
11/15/2007US20070264286 Tuberculosis Vaccines Including Recombinant BCG Strains Expressing Alanine Dehydrogenase, Serine Dehydratase and/or Glutamine Synthetase
11/15/2007US20070264285 Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof
11/15/2007US20070264284 Therapeutic, Prophylactic and Diagnostic Agents for Hepatitis B
11/15/2007US20070264283 Vaccine
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264281 Vaccination Vectors Derived From Lymphotropic Human Herpes Viruses 6 and 7
11/15/2007US20070264279 Compositions and methods comprising a MAGE-b antigen
11/15/2007US20070264277 Compositions and Methods of Use for Mgd-Csf in Disease Treatment
11/15/2007US20070264275 Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264260 Treatment methods using anti-CD22 antibodies
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264253 Human Anti-Epidermal Growth Factor Receptor Antibody
11/15/2007US20070264251 C1q Related Protein
11/15/2007US20070264249 Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264236 Novel Therapeutic Fusion Proteins
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264232 Cell populations which co-express CD49c and CD90
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007US20070262068 Reaction System for Thermal Cycling
11/15/2007DE10360483B4 Expressionsvektor und dessen Verwendung Expression vector and its use
11/15/2007DE102006022224A1 Subtilisin aus Bacillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin Subtilisin from Bacillus pumilus and detergents and cleaning agents containing this new subtilisin
11/15/2007DE102006022216A1 Neue Alkalische Protease aus Bacillus gibsonii und Wasch- und Reinigungsmittel enthaltend diese neue Alkalische Protease New alkaline protease from Bacillus gibsonii and detergents and cleaning agents containing these novel alkaline protease
11/15/2007CA2846817A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2846756A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2846732A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2685900A1 Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
11/15/2007CA2652599A1 Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
11/15/2007CA2651723A1 A novel group of esterases for the enantioselective production of fine and speciality chemicals
11/15/2007CA2651572A1 Use of cells containing a specific dna molecule as cytopathic agents to inhibit the proliferation of cells
11/15/2007CA2651348A1 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007CA2651216A1 Aptamers directed to muc1
11/15/2007CA2651137A1 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof
11/15/2007CA2651117A1 Method for producing stable mammalian cell lines producing high levels of recombinant proteins
11/15/2007CA2651088A1 Selection of host cells expressing protein at high levels
11/15/2007CA2650861A1 Improved gene silencing methods
11/15/2007CA2650734A1 Production of sialylated n-glycans in lower eukaryotes
11/15/2007CA2649962A1 Hcv coreceptor and methods of use thereof
11/15/2007CA2649932A1 Microbial intestinal delivery of obesity related peptides
11/15/2007CA2649876A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2648487A1 Polypeptide antagonist
11/15/2007CA2646641A1 Fermentive production of four carbon alcohols
11/15/2007CA2645497A1 Fermentive production of four carbon alcohols
11/15/2007CA2638785A1 Anti-ephb4 antibodies and methods using same
11/15/2007CA2636998A1 Polymorphisms in growth hormone receptor, ghrelin, leptin, neuropeptide y, and uncoupling protein 2 genes and their associations with measures of performance and carcass merit in beef cattle
11/14/2007EP1854896A2 A method and test kit for quantitative determination of variations in polynucleotide amounts in cell or tissue samples
11/14/2007EP1854895A1 Signal amplification method
11/14/2007EP1854892A1 Modified viral surface proteins wich bind to cells of tumor vasculature
11/14/2007EP1854891A1 New neomycin phosphotransferase genes and method for selecting highly productive recombining cells
11/14/2007EP1854890A1 Expression cloning in filamentous fungi
11/14/2007EP1854889A1 Genetically modified cyanobacteria for the production of ethanol
11/14/2007EP1854888A2 Expression-regulating sequences and expression products in Chrysosporium
11/14/2007EP1854886A2 Cold-adapted equine influenza viruses
11/14/2007EP1854885A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854883A1 Assist probes and method of using the same
11/14/2007EP1854882A1 Method for obtaining subtraction polynucleotide
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 4023